| Ytd | -81.74% | |
| 1y | -92.27% |
| Open | 1.83 | Prev Close | 1.81 | Low | 1.73 | High | 1.83 | Mkt Cap | 1.17M |
| Vol | 17.57K | Avg Vol | 107.57K | EPS | -8.49 | P/E | -0.21 | Forward P/E | 3.83 |
| Beta | 4.18 | Short Ratio | 1.25 | Inst. Own | 14.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.51 | 200-d Avg | 5.63 | 1yr Est | 12.00 |
Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical t
Precision testing confirms reproducibility across more than 1,600 tests, three production runs, and
On Thursday, 369 companies hit new 52-week lows.
On Monday, 369 companies set new 52-week lows.